mRNA Processing: An Emerging Frontier in the Regulation of Pancreatic β Cell Function

Robust endocrine cell function, particularly β cell function, is required to maintain blood glucose homeostasis. Diabetes can result from the loss or dysfunction of β cells. Despite decades of clinical and basic research, the precise regulation of β cell function and pathogenesis in diabetes remains...

Full description

Bibliographic Details
Main Authors: Nicole D. Moss, Lori Sussel
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Genetics
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fgene.2020.00983/full
id doaj-54abc3dba03445d5a46bb06673e85ca6
record_format Article
spelling doaj-54abc3dba03445d5a46bb06673e85ca62020-11-25T03:52:11ZengFrontiers Media S.A.Frontiers in Genetics1664-80212020-09-011110.3389/fgene.2020.00983579971mRNA Processing: An Emerging Frontier in the Regulation of Pancreatic β Cell FunctionNicole D. MossLori SusselRobust endocrine cell function, particularly β cell function, is required to maintain blood glucose homeostasis. Diabetes can result from the loss or dysfunction of β cells. Despite decades of clinical and basic research, the precise regulation of β cell function and pathogenesis in diabetes remains incompletely understood. In this review, we highlight RNA processing of mRNAs as a rapidly emerging mechanism regulating β cell function and survival. RNA-binding proteins (RBPs) and RNA modifications are primed to be the next frontier to explain many of the poorly understood molecular processes that regulate β cell formation and function, and provide an exciting potential for the development of novel therapeutics. Here we outline the current understanding of β cell specific functions of several characterized RBPs, alternative splicing events, and transcriptome wide changes in RNA methylation. We also highlight several RBPs that are dysregulated in both Type 1 and Type 2 diabetes, and discuss remaining knowledge gaps in the field.https://www.frontiersin.org/article/10.3389/fgene.2020.00983/fullpancreatic isletbeta cellsdiabetesRNA processingRNA binding proteins
collection DOAJ
language English
format Article
sources DOAJ
author Nicole D. Moss
Lori Sussel
spellingShingle Nicole D. Moss
Lori Sussel
mRNA Processing: An Emerging Frontier in the Regulation of Pancreatic β Cell Function
Frontiers in Genetics
pancreatic islet
beta cells
diabetes
RNA processing
RNA binding proteins
author_facet Nicole D. Moss
Lori Sussel
author_sort Nicole D. Moss
title mRNA Processing: An Emerging Frontier in the Regulation of Pancreatic β Cell Function
title_short mRNA Processing: An Emerging Frontier in the Regulation of Pancreatic β Cell Function
title_full mRNA Processing: An Emerging Frontier in the Regulation of Pancreatic β Cell Function
title_fullStr mRNA Processing: An Emerging Frontier in the Regulation of Pancreatic β Cell Function
title_full_unstemmed mRNA Processing: An Emerging Frontier in the Regulation of Pancreatic β Cell Function
title_sort mrna processing: an emerging frontier in the regulation of pancreatic β cell function
publisher Frontiers Media S.A.
series Frontiers in Genetics
issn 1664-8021
publishDate 2020-09-01
description Robust endocrine cell function, particularly β cell function, is required to maintain blood glucose homeostasis. Diabetes can result from the loss or dysfunction of β cells. Despite decades of clinical and basic research, the precise regulation of β cell function and pathogenesis in diabetes remains incompletely understood. In this review, we highlight RNA processing of mRNAs as a rapidly emerging mechanism regulating β cell function and survival. RNA-binding proteins (RBPs) and RNA modifications are primed to be the next frontier to explain many of the poorly understood molecular processes that regulate β cell formation and function, and provide an exciting potential for the development of novel therapeutics. Here we outline the current understanding of β cell specific functions of several characterized RBPs, alternative splicing events, and transcriptome wide changes in RNA methylation. We also highlight several RBPs that are dysregulated in both Type 1 and Type 2 diabetes, and discuss remaining knowledge gaps in the field.
topic pancreatic islet
beta cells
diabetes
RNA processing
RNA binding proteins
url https://www.frontiersin.org/article/10.3389/fgene.2020.00983/full
work_keys_str_mv AT nicoledmoss mrnaprocessinganemergingfrontierintheregulationofpancreaticbcellfunction
AT lorisussel mrnaprocessinganemergingfrontierintheregulationofpancreaticbcellfunction
_version_ 1724483854132051968